Press Releases

BUFFALO, NY - Christine Ambrosone, PhD, Chair of Cancer Prevention and Control and Kelvin Lee, MD, Chair of Immunology at Roswell Park Comprehensive Cancer Center, have received a grant for $165,000 from the Breast Cancer Research Foundation to study the possible link between adaptation to endemi

BUFFALO, NY - The Technology Transfer Office of Roswell Park Comprehensive Cancer Center announced it has signed a licensing agreement with Zhejiang Hisun Pharmaceutical Co. Ltd., for tumor imaging technology developed by Roswell Park researcher Ravindra Pandey, PhD.

BUFFALO, NY - Roswell Park Comprehensive Cancer Center is the recipient of a grant from Susan G. Komen for the Cure for $186,000 to support research exploring the role of certain genetic markers in the development of breast cancer.

The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Clinical Practice Guidelines for Oncology™ for Prostate Cancer to reflect new recommendations regarding active surveillance, also referred to as watchful waiting, for men with low risk prostate cancer.

BUFFALO, NY - Roswell Park Comprehensive Cancer Center ranks in the 96th percentile nationwide for overall patient satisfaction, according to the 2009 Press, Ganey Inpatient Satisfaction Survey, which rates more than 1,000 hospitals across the country.

Roswell Park Comprehensive Cancer Center announced an Institutional Research Grant (IRG) for $180,000 from the American Cancer Society to provide pilot funding for junior-level investigators.

Buffalo, NY - Most patients with anal cancer receive radiation as part of their treatment plan, but the anus is “a very sensitive area of the human body, almost like the fingertips,” notes Gary Yang, MD, Director of Gastrointestinal Radiation Medicine at Roswell Park Comprehensive Cancer Center.

Initial results from a large, randomized clinical trial for patients with multiple myeloma, a cancer of the blood and bone marrow, showed that patients who received the oral drug lenalidomide (Revlimid, also known as CC-5013) following a blood stem cell transplant had their cancer kept in check l

Network affiliation will produce exciting and dynamic opportunities for patients and Meadville Medical Center staff